Ian T Bothwell Organicell Regenerative Medicine, Inc. (OCEL) insider trading activity

Ian T Bothwell is Interim CEO & CFO of Organicell Regenerative Medicine, Inc.. Currently has a direct ownership of 50 shares of OCEL, which is worth approximately $57. The most recent transaction as insider was on May 14, 2021, when has been sold 50,000 shares (Common Stock) at a price of $0.24 per share, resulting in proceeds of $12,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50

100.0% 3M change

100.0% 12M change

Total Value Held $57

IAN T BOTHWELL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 14 2021	SELL Open market or private sale	$12,000 $0.24 p/Share	50,000 Reduced 0.03%	149,645,000 Common Stock
May 13 2021	SELL Open market or private sale	$13,500 $0.27 p/Share	50,000 Reduced 0.03%	149,695,000 Common Stock
May 12 2021	SELL Open market or private sale	$13,000 $0.26 p/Share	50,000 Reduced 0.03%	149,745,000 Common Stock
May 11 2021	SELL Open market or private sale	$17,500 $0.35 p/Share	50,000 Reduced 0.03%	149,795,000 Common Stock
May 10 2021	SELL Open market or private sale	$13,500 $0.27 p/Share	50,000 Reduced 0.03%	149,845,000 Common Stock
May 07 2021	SELL Open market or private sale	$23,400 $0.26 p/Share	90,000 Reduced 0.06%	149,895,000 Common Stock
May 06 2021	SELL Open market or private sale	$10,400 $0.26 p/Share	40,000 Reduced 0.03%	149,985,000 Common Stock
May 05 2021	SELL Open market or private sale	$21,750 $0.29 p/Share	75,000 Reduced 0.05%	150,025,000 Common Stock
May 04 2021	SELL Open market or private sale	$21,000 $0.42 p/Share	50,000 Reduced 0.03%	150,100,000 Common Stock
May 03 2021	SELL Open market or private sale	$12,500 $0.25 p/Share	50,000 Reduced 0.03%	150,150,000 Common Stock
Apr 30 2021	SELL Open market or private sale	$22,500 $0.45 p/Share	50,000 Reduced 0.03%	150,200,000 Common Stock
Apr 29 2021	SELL Open market or private sale	$22,500 $0.45 p/Share	50,000 Reduced 0.03%	150,250,000 Common Stock
Apr 06 2021	BUY Grant, award, or other acquisition	-	5,000,000 Added 3.22%	150,300,000 Common Stock
Feb 10 2021	BUY Grant, award, or other acquisition	-	5,000,000 Added 3.33%	145,300,000 Common Stock
Jan 27 2021	BUY Grant, award, or other acquisition	-	5,000,000 Added 3.44%	140,300,000 Common Stock
Dec 21 2020	BUY Grant, award, or other acquisition	-	15,000,000 Added 9.98%	135,300,000 Common Stock
Sep 23 2020	BUY Grant, award, or other acquisition	$1,960,000 $0.28 p/Share	7,000,000 Added 6.23%	105,300,000 Common Stock
Sep 17 2020	BUY Grant, award, or other acquisition	$150,000 $0.03 p/Share	5,000,000 Added 3.99%	120,300,000 Common Stock
Sep 03 2020	BUY Grant, award, or other acquisition	$150,000 $0.03 p/Share	5,000,000 Added 4.16%	115,300,000 Common Stock
Aug 25 2020	BUY Grant, award, or other acquisition	$150,000 $0.03 p/Share	5,000,000 Added 4.34%	110,300,000 Common Stock

ITB

Ian T Bothwell

Interim CEO & CFO

Miami, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCEL shares.

Notify only if

Value

Insider Trading

Get notified when an Organicell Regenerative Medicine, Inc. insider buys or sells OCEL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Organicell Regenerative Medicine, Inc.

Track Activities on OCEL

Account